Table 1.
Linear modela
| Stomach | Liver | Lung | |
| gender | M/F | M/F | M/F |
| casesb | 1482 | 540 | 524 |
| φmc | 6.66 | 38.58 | 16.90 |
| ca Dφ > 0d | 1412 | 172 | 494 |
| LRTlin-cone | 2.09 | 11.21 | 2.26 |
| ERR1,φfg | 0.09 (-0.03, 0.22) | 0.69 (0.25, 1.26) | 0.16 (-0.05, 0.42) |
| Devh | 1680.64 | 1258.02 | 1052.43 |
| Chi-sqi | 3205.08 | 2389.85 | 2500.37 |
| dfj | 2992 | 2992 | 2992 |
| Excessk | 38.13 | 27.17 | 23.20 |
| Colon | Uterus | All solid | |
| gender | M/F | F | M/F |
| casesb | 214 | 263 | 4379 |
| φmc | 43.91 | 6.12 | 43.86 |
| ca Dφ > 0d | 33 | 262 | 365 |
| LRTlin-cone | 0.19 | 0.51 | 5.03 |
| ERR1, φfg | 0.17 (-0.44, 1.17) | 0.10 (-0.16, 0.44) | 0.26 (0.03, 0.52) |
| Devh | 719.80 | 638.46 | 2133.03 |
| Chi-sqi | 3497.50 | 1010.56 | 2769.51 |
| dfj | 2992 | 1513 | 2992 |
| Excessk | 1.51 | 8.88 | 25.01 |
a 0 – 20 mSv subcohort, Excess Relative Risk ERR = βDφ with β constrained by 1 + ERR ≥ 0 for all data cells. Dφ is the weighted adjusted colon dose (neutron RBE = 10), lagged by φ years, in 10 mSv units. The control model is nested by β = 0.
b deaths in the subcohort from the specified cancer
c Latency φm is chosen in the range 5 – 44 years. to minimise linear model Deviance for the given cancer site and gender. Where italicised, φm minimises Dev subject to ERR ≥ 0, equivalent to β ≥ 0
d deaths in the subcohort from the specified cancer, for which Dφ > 0 where φ = φm
e The likelihood ratio test LRTlin-con compares the fitted linear model with the control model at φm and is χ2 distributed on 1 degree of freedom
f ERR1,φ is the Excess Relative Risk at Dφ = 1 with φ = φm
g 95% Profile Likelihood Confidence Intervals are calculated with φ fixed at φm
h Deviance of the fitted model
i Pearson Chi-Square of the fitted model
j Degrees of Freedom of the fitted model
k difference between Observed (= Expected) cases and the number expected if Dφ is set to 0 in every cell after fitting the model